KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 8 analysts with an average price target of $192.65. This is a potential upside of $32.98 (20.66%) from yesterday's end of day stock price of $159.67.

Krystal Biotech's activity chart (see below) currently has 46 price targets and 53 ratings on display. The stock rating distribution of KRYS is 93.1% BUY and 6.9% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 99.57% with an average time for these price targets to be met of 301.82 days.

Highest price target for KRYS is $200, Lowest price target is $130, average price target is $192.65.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 22-Apr-2024. First documented stock forecast 28-Jun-2018.

Currently out of the existing stock ratings of KRYS, 27 are a BUY (93.1%), 2 are a HOLD (6.9%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

200

$40.33 (25.26%)

139

10 days ago

20/21 (95.24%)

$42.75 (27.19%)

237

Buy

175

$15.33 (9.60%)

130

2 months 5 days ago

4/4 (100%)

$4.85 (2.85%)

135

Buy

180

$20.33 (12.73%)

160

4 months 19 days ago

4/4 (100%)

$65.38 (57.04%)

139

Buy

153

$-6.67 (-4.18%)

148

8 months 25 days ago

7/7 (100%)

$44.49 (41.00%)

409

Buy

140

$-19.67 (-12.32%)

110

11 months 7 days ago

2/2 (100%)

$22.61 (19.26%)

383

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 301.82 days on average for the stock forecasts to be realized with a an average price target met ratio 99.57

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Joseph Pantginis with highest potential upside - $40.33

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?